Aquatic Capital Management LLC Anavex Life Sciences Corp. Transaction History

Aquatic Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$7.66 - $9.5 $49,790 - $61,750	-6,500 Reduced 67.71%	3,100 $25,000
Q1 2023 May 15, 2023	BUY	$8.32 - $11.75 $79,872 - $112,800	9,600 New	9,600 $82,000
Q3 2022 Nov 14, 2022	BUY	$8.9 - $12.86 $77,430 - $111,882	8,700 New	8,700 $90,000
Q2 2022 Aug 15, 2022	SELL	$7.31 - $12.84 $8,772 - $15,408	-1,200 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.74 - $17.69 $11,688 - $21,228	1,200 New	1,200 $15,000

163

27.5M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.